Headline: RERF Announces Competitive Bidding for Lumipulse G1200 Plus Immunoassay Analyzer System,放射線影響研究所


Okay, let’s break down the information about the “2025年度:3 「免疫発光測定装置(ルミパルスG1200 Plus)一式」の一般競争入札公示について” announcement from the Radiation Effects Research Foundation (RERF), published on May 19, 2025, at 02:00.

Headline: RERF Announces Competitive Bidding for Lumipulse G1200 Plus Immunoassay Analyzer System

In essence, this announcement signifies that the Radiation Effects Research Foundation (RERF) is seeking bids from companies to procure a complete Lumipulse G1200 Plus immunoassay analyzer system. Let’s unpack what each part means:

  • Radiation Effects Research Foundation (RERF): This is a joint Japanese-American research organization dedicated to studying the long-term health effects of radiation exposure, primarily focusing on the survivors of the atomic bombings of Hiroshima and Nagasaki. Their website is https://www.rerf.or.jp/. They conduct extensive epidemiological studies and research.

  • 2025年度 (2025 Fiscal Year): This indicates that the procurement is planned for the Japanese fiscal year 2025, which typically runs from April 1, 2025, to March 31, 2026.

  • 3: likely indicates that this is the 3rd procurement announcement of the 2025 fiscal year.

  • 一般競争入札 (General Competitive Bidding): This is the key phrase. It means RERF is using a transparent and open process to select the supplier. Any qualified company can submit a bid, and the selection will be based on pre-defined criteria. This ensures fairness and cost-effectiveness.

  • 免疫発光測定装置 (Immunoassay Analyzer): This refers to a sophisticated laboratory instrument used to measure the concentration of specific substances (analytes) in biological samples (like blood, serum, or urine). These analytes can include hormones, proteins, antibodies, drugs, and other biomarkers.

  • ルミパルスG1200 Plus (Lumipulse G1200 Plus): This is the specific model of the immunoassay analyzer that RERF wants to purchase. The Lumipulse G1200 Plus is a commercially available immunoassay analyzer manufactured by Fujirebio.

  • 一式 (Is-shiki): This means “complete set” or “all-inclusive.” RERF isn’t just buying the analyzer itself; they want a complete system. This usually includes:

    • The main analyzer unit
    • Required software for operation and data analysis
    • Peripherals (e.g., a computer, printer, barcode scanner)
    • Consumables (initial supply of reagents, calibrators, and controls)
    • Installation and training
    • Warranty and service agreement

Why is RERF buying this equipment?

Knowing RERF’s mission, we can infer why they need this type of analyzer:

  • Health Studies: Immunoassay analyzers are crucial for analyzing samples collected from the atomic bomb survivors and their descendants. They allow researchers to measure biomarkers related to various health conditions, including cancer, cardiovascular disease, and other age-related illnesses.

  • Radiation Effects Research: The analyzer can be used to investigate the effects of radiation exposure on the immune system and other biological processes. Biomarkers detectable by immunoassay can reflect subtle changes caused by radiation.

  • Longitudinal Studies: RERF conducts long-term follow-up studies. An immunoassay analyzer enables them to track changes in biomarker levels over time, providing valuable insights into the long-term health consequences of radiation exposure.

Implications for Potential Bidders:

If you are a company that supplies the Lumipulse G1200 Plus or related equipment, this announcement is an opportunity to bid on a significant contract. You would need to:

  • Review the Official Tender Documents: The announcement on the RERF website is just a notification. To get the full details, you’d need to download the complete tender documents (likely linked from the announcement page). These documents will specify:

    • Detailed technical specifications for the system
    • Required documentation (company profile, financial statements, etc.)
    • Submission deadlines
    • Evaluation criteria (e.g., price, technical capabilities, service support)
    • Contract terms and conditions
  • Assess Eligibility: Ensure your company meets the eligibility requirements to bid on Japanese government contracts (or contracts from quasi-governmental organizations like RERF).

  • Prepare a Competitive Bid: Develop a compelling proposal that highlights the advantages of your offering, including competitive pricing, superior technical capabilities, reliable service support, and compliance with all RERF requirements.

In summary, the RERF’s announcement signifies their intent to acquire a Lumipulse G1200 Plus immunoassay analyzer system through a fair and open competitive bidding process. This purchase will likely enhance their research capabilities in studying the long-term health effects of radiation exposure.


2025年度:3 「免疫発光測定装置(ルミパルスG1200 Plus)一式」の一般競争入札公示について


The AI has delivered the news.

The following question was used to generate the response from Google Gemini:

At 2025-05-19 02:00, ‘2025年度:3 「免疫発光測定装置(ルミパルスG1200 Plus)一式」の一般競争入札公示について’ was published according to 放射線影響研究所. Please write a detailed article with related information in an easy-to-understand manner. Please answer in English.


2

Leave a Comment